Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06600620Suspended

Intelligent Monitoring to Predict Atrial Fibrillation

Role: collaborator

NCT04260230Not ApplicableWithdrawn

Remote Monitoring of Patients at Risk of Sepsis

Role: collaborator

NCT03480204Completed

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

Role: collaborator

All 3 trials loaded